Home

Akums Drugs & Pharmaceuticals Ltd PE Ratio

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

PE

55.7

Last updated on: Apr 22, 2025

Key Highlights

  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd is 55.7 as of 22 Apr 9.00 AM .
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 505.85 as of 22 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.9. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Akums Drugs & Pharmaceuticals Ltd

No data available

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

Share Price

₹ 505.85

3.60 (0.72%)

stock direction

Last updated on: Apr 22, 2025

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Apr 2025505.85
21 Apr 2025502.25
17 Apr 2025486.25
16 Apr 2025498.85
15 Apr 2025477.55
11 Apr 2025434.15
09 Apr 2025429.2
08 Apr 2025446.65
07 Apr 2025421.05
04 Apr 2025448.6

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Akums Drugs & Pharmaceuticals Ltd7961
Sun Pharmaceutical Industries Ltd419224
Divis Laboratories Ltd157046
Cipla Ltd123412
Torrent Pharmaceuticals Ltd109829
Mankind Pharma Ltd106262

PE Ratio of Akums Drugs & Pharmaceuticals Ltd Explained

7961

Market cap

149

Earnings

55.7X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Akums Drugs & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

Akums Drugs & Pharmaceuticals Ltd News Hub

Akums Drugs and Pharmaceuticals rises on debut

The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the stock has

Read more

06 Aug 24

Akums Drugs and Pharmaceuticals IPO ends with strong subscription

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bids for sha

Read more

02 Aug 24

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bids for sha

Read more

01 Aug 24

Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 202

Read more

26 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Akums Drugs & Pharmaceuticals Ltd

What is the current PE Ratio of Akums Drugs & Pharmaceuticals Ltd?

The Current PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 55.71 as on 22 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Apr 2025.

What was the PE Ratio of Akums Drugs & Pharmaceuticals Ltd last year?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 55.71, showing a year-on-year growth of -%.

What does the PE Ratio of Akums Drugs & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 55.71. This ratio indicates that investors are willing to pay 55.71 times the earnings per share for each share of Akums Drugs & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Akums Drugs & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -2.5.

How does the PE ratio of Akums Drugs & Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Akums Drugs & Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Akums Drugs & Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio?

The PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Akums Drugs & Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Akums Drugs & Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Akums Drugs & Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Akums Drugs & Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Akums Drugs & Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions